Advocacy
- Vascular Access
- Uncategorized
- Training
- Storytelling
- Sponsored
- Scheduling
- Risk Management
- Regulatory Comment
- Providers
- Press Release
- Pharmacology
- Patients
- Operations
- Legislative Comment
- Legal Risk Mitigation
- Legal
- Insurance
- Infusion Patients
- In The News
- Emergency Resources
- Disease Management
- Data Management
- Chronic Illness
- Billing
- Artificial Intelligence
- Advocacy
- Access Issues
In August 2026, NICA submitted comments to Senator Bill Cassidy, MD (R-La.) regarding his discussion draft of the 340B Drug Pricing Integrity and Affordability for Patients […]
In August 2026, NICA submitted comments to the House Republican and Democratic Doctors Caucuses on ways to strengthen Medicare’s physician payment system. NICA emphasized that more stable […]
In August 2026, NICA submitted comments to the Senate Finance Committee on proposals to lower prescription drug costs. NICA highlighted several policies that can affect what […]
In August 2026, NICA submitted comments to the Centers for Medicare & Medicaid Services (CMS) on proposed changes to the Medicare Drug Price Negotiation Program. NICA […]
In 2025, NICA’s advocacy work delivered meaningful wins for non-hospital infusion providers by elevating provider voices, shaping policy debates, and driving real-world results at the state […]
CMS is asking infusion providers to submit comments about selected drugs as part of the Medicare Drug Price Negotiation Program. This includes the first negotiations for […]
Government price setting policies, such as Upper Payment Limits (UPLs) established by Prescription Drug Affordability Boards (PDABs), can have real-world consequences for infusion providers and the […]
It’s Open Enrollment season!Open Enrollment is the annual period when patients review and adjust their health insurance coverage. For patients receiving infusion therapies, insurance choices can […]